Narayana Hrudayalaya Limited – Investor Presentation Summary
Key Operational Highlights
- Total healthcare facilities: 56 with 6,119 operational beds as of October 1, 2026.
- Total staff strength: ~21,150 (Clinical: ~13,100, Non-clinical: ~8,050).
- Geographic footprint: South India (7 hospitals, 2 heart centres, 15 clinics, 1 diagnostic centre, 2,291 beds), East India (7 hospitals, 3 clinics, 1 dialysis centre, 2,121 beds), North India (3 hospitals, 838 beds), West India (2 hospitals, 374 beds), Cayman Islands (2 facilities, 165 beds), United Kingdom (13 facilities, 330 beds).
- Key clinical achievements: South India's first Percutaneous Transcatheter Tricuspid Valve Replacement (TTVR), India's first Transcatheter Tricuspid Valve Implantation (TTVI) on a 14-year-old, 54 TAVIs and 6 hybrid percutaneous pulmonary valve implantations in Q2 FY27, highest volume of cardiac surgeries in a single day: 38 cases at Narayana Institute of Cardiac Sciences, Bengaluru.
Segment-wise Performance
India Operations (Q2 FY27):
- Operating Revenue: ₹14,402 Mn (QoQ growth: ▲8.7%, YoY growth: ▲16.6%)
- EBITDA: ₹3,548 Mn (QoQ growth: ▲22.3%, YoY growth: ▲30.8%)
- PAT: ₹1,899 Mn (QoQ growth: ▲44.2%, YoY growth: ▲36.2%)
- PAT Margin: 13.2% (vs 11.3% in Q2 FY26)
Cayman Islands Operations - HCCI (Q2 FY27):
- Operating Revenue: $63.4 Mn (QoQ growth: ▲8.9%, YoY growth: ▲28.2%)
- EBITDA: $22.1 Mn (QoQ growth: ▲46.4%, YoY growth: ▲23.8%)
- PAT: $16.6 Mn (QoQ growth: ▲62.9%, YoY growth: ▲20.9%)
- PAT Margin: 26.2% (vs 27.8% in Q2 FY26)
United Kingdom Operations - NHUK (Q2 FY27):
- Operating Revenue: £64.4 Mn (QoQ growth: ▼0.9%)
- EBITDA: £4.7 Mn (QoQ growth: ▼18.5%)
- PAT: -£2.7 Mn (QoQ growth: ▼22.1%)
- PAT Margin: -4.2% (vs -3.4% in Q1 FY27)
- New center loss for Q2 FY27: GBP 0.8 Mn
Financial Highlights
Consolidated Performance (Q2 FY27):
- Revenue: ₹28,440 Mn (QoQ: ▲6.0%, YoY: ▲73.0%)
- EBITDA: ₹6,054 Mn (QoQ: ▲19.8%, YoY: ▲42.0%)
- EBITDA Margin: 21.3%
- PAT: ₹3,012 Mn (QoQ: ▲45.3%, YoY: ▲16.6%)
- PAT Margin: 10.6% (vs 15.7% in Q2 FY26)
- EPS: Not Specified
Expense Breakdown (Q2 FY27):
- Consumption: ₹5,477 Mn
- Doctors Expenses: ₹3,432 Mn
- Employee (Excluding Doctors) Expenses: ₹7,359 Mn
- Other Admin Expenses: ₹6,634 Mn
- Total Expenses: ₹22,901 Mn
- Other Income: ₹515 Mn
Drivers of financial performance: Higher revenue growth across India and Cayman operations, operational efficiencies.
Geographical Revenue Split
Domestic vs International:
- Detailed breakdown not specified in presentation
- International operations include Cayman Islands ($63.4 Mn revenue) and United Kingdom (£64.4 Mn revenue)
Balance Sheet Snapshot
As on September 30, 2026:
- Shareholder Equity: ₹50,054 Mn
- Borrowings + Lease Liability: ₹60,753 Mn
- Net Block + CWIP: ₹49,685 Mn
- Goodwill: ₹14,133 Mn
- Right to Use Assets: ₹9,596 Mn
- Net Receivables: ₹9,619 Mn
- Current Investments: ₹10,451 Mn
- Cash and Bank Balance: ₹19,398 Mn
- Net Debt to Equity Ratio: 0.38
Capex & Cash Flow Health
Net Debt Position (as on September 30, 2026):
- India: Net Debt ₹8,501 Mn (Gross Debt: ₹19,852 Mn, Cash: ₹11,351 Mn)
- Cayman Islands: Net Debt -$6,781 Mn (Gross Debt: $10,805 Mn, Cash: $17,586 Mn)
- United Kingdom: Net Debt £17,111 Mn (Gross Debt: £18,991 Mn, Cash: £1,880 Mn)
- Consolidated: Net Debt ₹18,830 Mn (Gross Debt: ₹49,648 Mn, Cash: ₹30,818 Mn)
Foreign Currency Debt Exposure:
- US Dollar denominated debt: $114 Mn
- British Pound denominated debt: £150 Mn
Strategic & Digital Initiatives
Digital Hospital Implementation:
- Banashankari Digital Hospital commenced operations in last week of September 2026
- OP Journey: Paperless registration, touch-free consultation invoicing, counter-free service invoicing, live queue tracking, green-channel pharmacy
- IP Journey: Upfront cost estimate, one-tap digital consent, paperless admission, always-on IP companion, discharge without delay, digital gate pass
Expansion Status:
- Project South-West Bangalore (Banashankari Hospital) operational from last week of September 2026
- Nagarabhavi Clinic commenced operations in last week of September 2026
ESG Updates
Environmental Performance:
- Renewable electricity consumption: 37% of total consumption (revised from 41% due to exclusion of one hospital)
- Water consumption efficiency: 48.87 KL/Bed/Day
- Energy consumption efficiency: 66.70 kWh/Bed/Day
- GHG emissions intensity: 0.045 tCO2e/Bed/Day
Management Commentary & Growth Outlook
Strategic Outlook: Not explicitly stated in presentation
FY Guidance: Not provided in presentation
Risks and Opportunities: Forward-looking statements caution about potential changes in business, competitive environment, and political, economic, legal and social conditions in India
Shareholding Pattern
As on September 30, 2026:
- Total Number of Shares: 204,360,804
- Key DIIs: Mirae Asset Management, Parag Parikh Asset Management, Nippon Life India Asset Management, Axis Asset Management, DSP Asset Management, Unifi Capital
- Key FIIs: Vanguard Index Fund, Franklin Templeton Investment Funds, Simcah Partners LP, iShares by Blackrock, Government Pension Fund Global, Mirae Asset Fund